Skip to content
PDRN Care
WikiBiological Processes

Wound Healing and Tissue Regeneration

Dr. Sarah Chen

Dr. Sarah Chen

PhD, Molecular Biology

5 minMarch 15, 2025Updated March 25, 2026
Definition

Wound healing is a complex, coordinated biological process through which the body repairs damaged tissue [1].

Definition

Wound healing is a complex, coordinated biological process through which the body repairs damaged tissue [1]. It proceeds through four overlapping phases — hemostasis, inflammation, proliferation, and remodeling — each governed by specific growth factors, cytokines, and cell populations [1][5]. PDRN was originally developed as a pharmaceutical agent to accelerate wound healing, particularly in conditions where normal repair is impaired, such as diabetic ulcers and ischemic wounds [2][3].

Phases of Wound Healing

Phase 1: Hemostasis (Minutes)

Immediately after tissue injury, platelets aggregate at the wound site, forming a fibrin clot that stops bleeding and creates a provisional matrix [1]. Platelets release growth factors (PDGF, TGF-β) that recruit immune cells and fibroblasts to the wound [1][5].

Phase 2: Inflammation (Days 1-5)

Neutrophils and macrophages infiltrate the wound to clear debris, bacteria, and damaged cells [1]. Pro-inflammatory cytokines (TNF-α, IL-1β, IL-6) coordinate the immune response [1][4]. This phase is essential but must resolve for healing to progress — chronic inflammation stalls wound repair [1][5].

PDRN's role: PDRN's A2A receptor activation modulates the inflammatory phase by suppressing NF-κB-mediated cytokine production without ablating the necessary immune response [3][4]. This helps transition the wound from inflammation to proliferation more efficiently [3].

Phase 3: Proliferation (Days 4-21)

The proliferative phase involves three concurrent processes [1][5]:

  • Angiogenesis — New blood vessels grow into the wound bed, restoring oxygen and nutrient delivery. VEGF is the primary driver [1][2][5]
  • Fibroplasia — Fibroblasts migrate into the wound and synthesize new extracellular matrix (collagen, hyaluronic acid, fibronectin) [1][5]
  • Re-epithelialization — Keratinocytes at wound edges proliferate and migrate across the wound surface to restore the epidermal barrier [1]

PDRN's role: PDRN directly enhances all three proliferative processes. It upregulates VEGF expression for angiogenesis [2], stimulates fibroblast proliferation and collagen synthesis [3][6], and provides nucleotide building blocks through the salvage pathway for the DNA synthesis required by rapidly dividing cells [3][6].

Phase 4: Remodeling (Weeks to Months)

The final phase involves maturation of the newly formed tissue [1]. Collagen type III (produced early in healing) is gradually replaced by stronger collagen type I [1][5]. The extracellular matrix is reorganized, and excess cells undergo apoptosis [1]. This phase can continue for 12 months or longer, and the quality of remodeling determines the final appearance of the healed tissue [1].

PDRN's role: By establishing a healthier tissue foundation during the proliferative phase — more organized collagen deposition, better vascularization — PDRN promotes superior remodeling outcomes [2][3][6].

Impaired Wound Healing

Several conditions impair normal wound healing, creating a clinical need for regenerative therapies like PDRN [1][2][5]:

  • Diabetes — Hyperglycemia impairs neutrophil function, reduces growth factor expression, and damages microvasculature [1][2]
  • Ischemia — Reduced blood flow deprives the wound of oxygen and nutrients necessary for repair [2]
  • Aging — Age-related decline in fibroblast function, growth factor production, and immune efficiency slows healing [1][5]
  • Chronic inflammation — Wounds trapped in the inflammatory phase (chronic ulcers) cannot progress to proliferation [1][4]

PDRN has demonstrated efficacy in each of these impaired healing contexts. In a landmark study, PDRN significantly accelerated wound closure in genetically diabetic mice by stimulating angiogenesis and overcoming the growth factor deficiency characteristic of diabetic wounds [2].

Relevance to Aesthetic Dermatology

The same wound healing biology that makes PDRN effective for chronic ulcers also explains its aesthetic benefits [3][6]:

  • Post-procedure recovery — Laser treatments, microneedling, and chemical peels create controlled wounds. PDRN accelerates the healing of these intentional injuries [3]
  • Skin rejuvenation — Photoaged skin exhibits many of the same features as chronic wounds: reduced collagen, impaired vasculature, chronic low-grade inflammation [3][6]. PDRN addresses all three through the same mechanisms it uses in wound healing
  • Scar prevention — By promoting organized collagen deposition and adequate angiogenesis during healing, PDRN may improve the quality of scar remodeling [2][3]

Understanding wound healing biology clarifies why PDRN's effects are progressive rather than instantaneous — the biological remodeling processes require weeks to months to produce visible changes, mirroring the natural timeline of tissue repair [1][3].

Reviewed by Dr. Min-Ji Park, MD, Board-Certified Dermatologist

References

  1. [1]
    Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature. 2008;453(7193):314-321. doi:10.1038/nature07039
  2. [2]
    Galeano M, Bitto A, Altavilla D, et al.. Polydeoxyribonucleotide stimulates angiogenesis and wound healing in the genetically diabetic mouse. Wound Repair Regen. 2008;16(2):208-217. doi:10.1111/j.1524-475X.2008.00361.x
  3. [3]
    Squadrito F, Bitto A, Irrera N, et al.. Pharmacological Activity and Clinical Use of PDRN. Curr Pharm Des. 2017;23(27):3948-3957. doi:10.2174/1381612823666170516153716
  4. [4]
    Bitto A, Polito F, Irrera N, et al.. Polydeoxyribonucleotide reduces cytokine production and the severity of collagen-induced arthritis by stimulation of adenosine A2A receptor. Arthritis Res Ther. 2011;13(1):R28. doi:10.1186/ar3254
  5. [5]
    Barrientos S, Stojadinovic O, Golinko MS, Brem H, Tomic-Canic M. Growth factors and cytokines in wound healing. Wound Repair Regen. 2008;16(5):585-601. doi:10.1111/j.1524-475X.2008.00410.x
  6. [6]
    Veronesi F, Dallari D, Sabbioni G, Carubbi C, Martini L, Fini M. Polydeoxyribonucleotides (PDRNs): From Physical Chemistry to Biological Activities and Clinical Applications. Int J Mol Sci. 2017;18(9):1927. doi:10.3390/ijms18091927
ShareTwitterLinkedIn

Search

Search across products, blog posts, wiki articles, and more.